News
NVS
149.73
-1.55%
-2.35
Trump names Erica Schwartz CDC Director
TipRanks · 12h ago
Trump Trade: White House launches space nuclear initiative
TipRanks · 17h ago
Drugmakers raised prices on hundreds of drugs, NBC News reports
TipRanks · 18h ago
Tango Therapeutics names Matthew Gall CFO, replacing Daniella Beckman
PUBT · 1d ago
Borouge International names Patrick Jany CFO from May 1
PUBT · 1d ago
Novartis CEO to join Anthropic board, WSJ reports
TipRanks · 1d ago
3 Best Vanguard Dividend ETFs for Reliable Passive Income in 2026
TipRanks · 1d ago
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
TipRanks · 2d ago
Citi Reaffirms Their Buy Rating on Novartis AG (NOVN)
TipRanks · 2d ago
Anthropic adds Novartis CEO Vas Narasimhan to its board
Reuters · 2d ago
Anthropic adds Novartis CEO Narasimhan to board of directors: report
Seeking Alpha · 2d ago
*Anthropic Adds Novartis CEO to Board, Company Says
The Wall Street Journal · 2d ago
Anthropic Adds Novartis CEO to Board
The Wall Street Journal · 2d ago
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times
NASDAQ · 3d ago
Weekly Report: what happened at NVS last week (0406-0410)?
Weekly Report · 3d ago
Voyager Therapeutics: 'Strong Buy' On Inflection Points For VY7523 In AD For 2026
Seeking Alpha · 4d ago
Novartis AG (NOVN) Gets a Hold from UBS
TipRanks · 04/10 06:55
FOCUS-Patients scramble to find estrogen patches as shortage worsens after US FDA champions use
Reuters · 04/09 10:00
Novartis broadens global community health initiatives, aiming to reach over 30 countries by 2030
Seeking Alpha · 04/09 08:59
Affluent Medical names Anne Lange to board, replaces Soad El Gazaoui
Reuters · 04/09 05:31
More
Webull provides a variety of real-time NVS stock news. You can receive the latest news about Novartis through multiple platforms. This information may help you make smarter investment decisions.
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.